BRD4 and cancer: Recent studies have demonstrated that epigenetic regulators are becoming new therapeutic targets for cancer therapy [6], of which as a member of the bromodomain and extraterminal domain (BET) proteins, bromodomain-containing protein 4 (BRD4) has been widely investigated.